All Episodes

October 27, 2022 50 mins

Carlo Ledesma is a Doctor of Clinical Laboratory Science resident at the Oklahoma City VA Health System. He is a certified medical laboratory scientist, a specialist in hematology, a qualification in laboratory safety, and a diplomate in laboratory management. He also serves as the program director for the Medical Lab Technology at Rose State College in Midwest City, Oklahoma. 

 His lab career started in Manila, Philippines where he obtained his B.S. in Medical Technology from the University of Santo Tomas. He started as a Microbiology laboratory assistant and worked in different settings and assumed different roles in the clinical laboratory including technical supervisor, quality assurance specialist, and laboratory administrative director. His technical expertise is in hematology, molecular diagnostics, technical consulting, and regulatory compliance.

 His doctoral work is in the laboratory's role in gender-affirming care to which he has presented some technical updates during this year's ASCLS annual meeting and wrote articles in ASCLS today.  He is this year's recipient of ASCP's Excellence in Education Award .


Twitter:
TikTok: CarloTheMedLabGuy (@carlothemedicallabguy) TikTok | Watch CarloTheMedLabGuy's Newest TikTok Videos

Mark as Played

Advertise With Us

Popular Podcasts

United States of Kennedy
Stuff You Should Know

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.